Mary Chapman, features writer —

Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.

Articles by Mary Chapman

OncLive Poised to Induct 2019 Class of ‘Giants of Cancer Care’

OncLive, a digital resource platform for oncologists, will welcome 15 new members at its 7th Annual Giants of Cancer Care Winners Reception on May 30 in Chicago, Illinois. Inductees are being recognized for furthering the field of oncology, including multiple myeloma, through research and clinical practices. “We are looking forward to honoring…

bluebird bio Opens Manufacturing, Research Facility in Durham, N.C.

Bluebird bio has officially opened a facility in Durham, North Carolina, to make the lentiviral vector needed for its investigational gene and cell treatments, including the CAR T-cell therapies bb2121 and bb21217 for relapsed or refractory multiple myeloma. Some 50 researchers, engineers and others are employed at the 125,000-square-foot…

Donation Will Establish Center for Multiple Myeloma Research in UK

Thanks to a £10 million donation (about $13,000,000), Imperial College London will establish a center for multiple myeloma research at the institution’s Hammersmith Hospital campus. The gift, from benefactors Hugh and Josseline Langmuir, will support blood cancer research at Imperial and advance research on more effective treatments for…